Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop

NCT05410379 is registered in ClinicalTrials.gov with Maria Cecilia Hospital as lead sponsor.

NCT NCT05410379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05410379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop
Lead sponsor
Maria Cecilia Hospital
Phase
Observational
Overall status
Completed
Start date
September 15, 2021
Completion date
March 15, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)